Status report
Get it in writing
The official USPTO status record for CLARITY, serial 99668477, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
CLARITYSerial 99668477 · Principal Register
Pending · Published for Opposition
Owner: Axsome Therapeutics, Inc.
Class 005 - Pharmaceuticals
Filed Feb 24, 2026
The record shows a live, pending application owned by Axsome Therapeutics, Inc., a Delaware corporation, and it is currently on the Principal Register. The filing covers “pharmaceutical preparations for the treatment of Major Depressive Disorder and Excessive Daytime Sleepiness; prescription medicines for the treatment of Major Depressive Disorder and Excessive Daytime Sleepiness” in International Class 5, so a later use of the word CLARITY in a similar pharmaceutical context would be the closest area of concern. The record does not give Axsome control over every use of the term in unrelated fields. The most recent meaningful event is the issuance of a Notice of Allowance on August 11 2026, which triggers a six‑month window for the applicant to file a Statement of Use or request an extension. The supplied history shows no oppositions, cancellations or other enforcement activity. I'd treat this as a meaningful concern if you plan a drug‑related brand that uses the same name.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.